Latest Share Chat

REMOVE ADS

Smiths Group Share News (SMIN)

Smiths Group Information

Share Price Information for Smiths Group (SMIN)

Share Price is delayed by 15 minutes

Get Live Data

2,493.00 74.00 (3.06%)

Bid:

2,491.00

Ask:

2,492.00

Spread: 1.00 (0.04%)

Market Cap: £7.41b

Last checked at -

Intraday Smiths Group Share Chart

REMOVE ADS

Smiths Group News

LONDON MARKET MIDDAY: Italy, Spain Woes Dent Stocks; Dixons Drops 20%

LONDON (Alliance News) - Stocks in London were seeing a disappointing session on Tuesday as the market re-opened from Monday's bank holiday, with the ...

WINNERS & LOSERS SUMMARY: Dixons Carphone Sinks As It Warns On Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNER...

LONDON MARKET OPEN: Dixons Tumbles As It Sees Further Profit Fall

LONDON (Alliance News) - Re-opening from Monday's bank holiday, stocks in London traded lower on Tuesday amid political uncertainty in Europe.In the F...

CORRECT: Smiths Group Confirms ICU Medical Merger Discussions

(Correcting that Smiths Group shares closed 0.5% up at 1,720.00 pence each at the close of trading on Friday, not that they were trading at that price...

TOP NEWS: Smiths Group Confirms ICU Medical Merger Discussions

LONDON (Alliance News) - Engineer Smiths Group PLC on Sunday confirmed it is in "very early stage" talks over merging its medical unit with Nasdaq-lis...

DIRECTOR DEALINGS SUMMARY: Smiths Group CFO, Non-Exec Buy Up Stock

LONDON (Alliance News) - The following is a summary of director dealings reported in London on Wednesday.----------Medical devices maker Smiths Group ...

DIRECTOR DEALINGS: Smiths CFO And Non-Executive Director Buy Shares

LONDON (Alliance News) - Medical devices maker Smiths Group PLC, said Wednesday Chief Financial Officer John Shipsey and Non-Executive Director Bill S...

EUROPE RESEARCH ROUNDUP-Ageas, Genmab, Roche Holding

March 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ageas SA, Genmab and Roche H...